A unique biomedical resource at risk

The completion of the draft sequence of the chimpanzee genome, the first non-human private genome to be sequenced, places the chimpanzee in a position to play an increasingly critical and invaluable role in biomedical advances. VandeBerg and Zola believe that lifting the current moratorium on breedi...

Full description

Saved in:

Bibliographic Details
Published in:	Nature Vol. 437; no. 7055; pp. 30 - 32
Main Authors:	VandeBerg, John L, Zola, Stuart M
Format:	Journal Article
Language:	English
Published:	England Nature Publishing Group 01-09-2005
Subjects:	Animal populations Animals Animals, Laboratory Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal - pharmacokinetics Antibodies, Monoclonal - therapeutic use Bioethics Biomedical research Biomedical Research - methods Biomedical Research - trends Breeding Clinical Trials as Topic Conservation of Natural Resources Disease Disease Models, Animal Drug Evaluation, Preclinical - trends Evolution, Molecular Female Genomics Global health Health problems Hepatitis HIV Infections Humans Internationality Male Monkeys & apes Pan troglodytes - genetics Pan troglodytes - parasitology Pan troglodytes - physiology Pan troglodytes - virology Viral Vaccines Biomedical and Behavioral Research
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The completion of the draft sequence of the chimpanzee genome, the first non-human private genome to be sequenced, places the chimpanzee in a position to play an increasingly critical and invaluable role in biomedical advances. VandeBerg and Zola believe that lifting the current moratorium on breeding chimpanzees in US research facilities is essential to preserve this unique resource, which is needed to solve some of the most important global health problems.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0028-0836 1476-4687
DOI:	10.1038/437030a